• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国私营部门医生和制药合同研究机构:一项定性研究。

United States private-sector physicians and pharmaceutical contract research: a qualitative study.

机构信息

Center for Biomedical Ethics & Society, Vanderbilt University, Nashville, Tennessee, United States of America.

出版信息

PLoS Med. 2012;9(7):e1001271. doi: 10.1371/journal.pmed.1001271. Epub 2012 Jul 24.

DOI:10.1371/journal.pmed.1001271
PMID:22911055
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3404112/
Abstract

BACKGROUND

There have been dramatic increases over the past 20 years in the number of nonacademic, private-sector physicians who serve as principal investigators on US clinical trials sponsored by the pharmaceutical industry. However, there has been little research on the implications of these investigators' role in clinical investigation. Our objective was to study private-sector clinics involved in US pharmaceutical clinical trials to understand the contract research arrangements supporting drug development, and specifically how private-sector physicians engaged in contract research describe their professional identities.

METHODS AND FINDINGS

We conducted a qualitative study in 2003-2004 combining observation at 25 private-sector research organizations in the southwestern United States and 63 semi-structured interviews with physicians, research staff, and research participants at those clinics. We used grounded theory to analyze and interpret our data. The 11 private-sector physicians who participated in our study reported becoming principal investigators on industry clinical trials primarily because contract research provides an additional revenue stream. The physicians reported that they saw themselves as trial practitioners and as businesspeople rather than as scientists or researchers.

CONCLUSIONS

Our findings suggest that in addition to having financial motivation to participate in contract research, these US private-sector physicians have a professional identity aligned with an industry-based approach to research ethics. The generalizability of these findings and whether they have changed in the intervening years should be addressed in future studies. Please see later in the article for the Editors' Summary.

摘要

背景

在过去的 20 年中,从事美国制药业赞助的临床试验的非学术性、私营部门医生的数量急剧增加。然而,对于这些调查员在临床研究中的作用所带来的影响,研究甚少。我们的目的是研究参与美国制药临床试验的私营诊所,以了解支持药物开发的合同研究安排,特别是从事合同研究的私营部门医生如何描述他们的专业身份。

方法和发现

我们在 2003-2004 年进行了一项定性研究,在美国西南部的 25 个私营研究机构进行了观察,并对这些诊所的医生、研究人员和研究参与者进行了 63 次半结构化访谈。我们使用扎根理论来分析和解释我们的数据。参与我们研究的 11 名私营部门医生报告说,他们成为行业临床试验的主要研究者,主要是因为合同研究提供了额外的收入来源。这些医生报告说,他们认为自己是试验从业者和商人,而不是科学家或研究人员。

结论

我们的研究结果表明,除了有参与合同研究的经济动机外,这些美国私营部门医生还有与基于行业的研究伦理方法相一致的专业身份。这些发现的普遍性以及它们在这几年中是否发生了变化,应该在未来的研究中加以解决。请在文章后面的“编者按”中查看。

相似文献

1
United States private-sector physicians and pharmaceutical contract research: a qualitative study.美国私营部门医生和制药合同研究机构:一项定性研究。
PLoS Med. 2012;9(7):e1001271. doi: 10.1371/journal.pmed.1001271. Epub 2012 Jul 24.
2
Practicing research ethics: private-sector physicians & pharmaceutical clinical trials.践行研究伦理:私营部门医生与药物临床试验
Soc Sci Med. 2008 Jun;66(12):2495-505. doi: 10.1016/j.socscimed.2008.02.001. Epub 2008 Mar 18.
3
Private sector risk-sharing agreements in the United States: trends, barriers, and prospects.美国私营部门风险分担协议:趋势、障碍与前景
Am J Manag Care. 2015 Sep;21(9):632-40.
4
Is the practice of public or private sector doctors more evidence-based? A qualitative study from Vellore, India.公立或私立部门医生的行医方式是否更基于证据?来自印度韦洛尔的一项定性研究。
Int J Evid Based Healthc. 2015 Jun;13(2):66-76. doi: 10.1097/XEB.0000000000000042.
5
Private sector contributions to pharmaceutical science: thirty-five summary case histories.私营部门对药物科学的贡献:三十五份案例总结。
Am J Ther. 2010 Jan-Feb;17(1):101-20. doi: 10.1097/MJT.0b013e3181ca7f10.
6
Compact versus contract--industry sponsors' obligations to their research subjects.紧密与契约——行业赞助商对其研究对象的义务
N Engl J Med. 2007 Jun 28;356(26):2737-43. doi: 10.1056/NEJMhle067499.
7
Aspects of research and development contract terms in the bio/pharmaceutical sector.生物制药领域研发合同条款的各个方面。
Adv Health Econ Health Serv Res. 2012;23:1-33. doi: 10.1108/s0731-2199(2012)0000023004.
8
[Mechanism and implication of regulation of the pricing of essential medicines in the private pharmaceutical sector in Mali].[马里私营制药部门基本药物定价监管的机制与影响]
Med Trop (Mars). 2010 Apr;70(2):184-8.
9
Private-sector research ethics: marketing or good conflicts management? The 2005 John J. Conley Lecture on Medical Ethics.私营部门的研究伦理:市场营销还是良好的冲突管理?2005年约翰·J·康利医学伦理讲座
Theor Med Bioeth. 2006;27(2):115-39. doi: 10.1007/s11017-005-5289-5.
10
The role of the private sector in biotechnology: research and development.私营部门在生物技术领域的作用:研发
Health Matrix Clevel. 2002 Summer;12(2):357-65.

引用本文的文献

1
Can research integrity prevail in the market? Lessons from commissioned research organizations.市场环境下能否坚持研究诚信?委托型研究组织的经验教训。
Account Res. 2022 Oct;29(7):415-441. doi: 10.1080/08989621.2021.1937603. Epub 2021 Jun 9.
2
Engaging African ancestry participants in SLE clinical trials.让有非洲血统的参与者参与系统性红斑狼疮临床试验。
Lupus Sci Med. 2018 Dec 11;5(1):e000297. doi: 10.1136/lupus-2018-000297. eCollection 2018.
3
Pharmaceutical companies and healthcare providers: Going beyond the gift - An explorative review.制药公司与医疗服务提供者:超越礼品——一项探索性综述
PLoS One. 2018 Feb 7;13(2):e0191856. doi: 10.1371/journal.pone.0191856. eCollection 2018.
4
Financial ties of principal investigators and randomized controlled trial outcomes: cross sectional study.主要研究者的经济利益关系与随机对照试验结果:横断面研究
BMJ. 2017 Jan 17;356:i6770. doi: 10.1136/bmj.i6770.
5
Knowledge, Beliefs and Attitudes of Patients and the General Public towards the Interactions of Physicians with the Pharmaceutical and the Device Industry: A Systematic Review.患者及普通公众对医生与制药和器械行业互动的认知、信念和态度:一项系统综述
PLoS One. 2016 Aug 24;11(8):e0160540. doi: 10.1371/journal.pone.0160540. eCollection 2016.
6
The potential exploitation of research participants in high income countries who lack access to health care.在高收入国家中,那些无法获得医疗保健服务的研究参与者可能会受到剥削。
Br J Clin Pharmacol. 2016 May;81(5):857-64. doi: 10.1111/bcp.12879. Epub 2016 Feb 29.
7
Exploring the Potential for Moral Hazard When Clinical Trial Research is Conducted in Rural Communities: Do Traditional Ethics Concepts Apply?探索在农村社区开展临床试验研究时出现道德风险的可能性:传统伦理观念适用吗?
HEC Forum. 2015 Jun;27(2):171-87. doi: 10.1007/s10730-015-9270-z.
8
Feasibility study of clinical trial for breast cancer and lung cancer at Indian sites.印度各站点乳腺癌和肺癌临床试验的可行性研究。
Perspect Clin Res. 2013 Oct;4(4):211-4. doi: 10.4103/2229-3485.120169.

本文引用的文献

1
Being the ghost in the machine: a medical ghostwriter's personal view.作为机器中的幽灵:医学代写作者的个人观点。
PLoS Med. 2011 Aug;8(8):e1001071. doi: 10.1371/journal.pmed.1001071. Epub 2011 Aug 9.
2
Re-inscribing Gender in New Modes of Medical Expertise: The Investigator-Coordinator Relationship in the Clinical Trials Industry.在医学专业知识的新模式中重新书写性别:临床试验行业中的研究者-协调者关系
Gend Work Organ. 2010 Mar 1;17(2):150-173. doi: 10.1111/j.1468-0432.2009.00464.x.
3
Commentary: Per capita payments in clinical trials: reasonable costs versus bounty hunting.述评:临床试验中的人均费用:合理成本与赏金猎人。
Acad Med. 2010 Oct;85(10):1554-6. doi: 10.1097/ACM.0b013e3181ef9cc6.
4
Outcome reporting among drug trials registered in ClinicalTrials.gov.临床试验注册中心登记的药物试验结局报告。
Ann Intern Med. 2010 Aug 3;153(3):158-66. doi: 10.7326/0003-4819-153-3-201008030-00006.
5
Oversight of financial conflicts of interest in commercially sponsored research in academic and nonacademic settings.对学术和非学术环境中商业赞助研究的财务利益冲突的监督。
J Gen Intern Med. 2010 May;25(5):460-4. doi: 10.1007/s11606-010-1264-6. Epub 2010 Feb 26.
6
Financing of U.S. biomedical research and new drug approvals across therapeutic areas.美国生物医学研究和各治疗领域新药批准的资金情况。
PLoS One. 2009 Sep 11;4(9):e7015. doi: 10.1371/journal.pone.0007015.
7
Getting to yes: corporate power and the creation of a psychopharmaceutical blockbuster.达成共识:企业权力与一种精神药物重磅产品的诞生
Cult Med Psychiatry. 2009 Jun;33(2):185-215. doi: 10.1007/s11013-009-9129-3.
8
Ethical and scientific implications of the globalization of clinical research.临床研究全球化的伦理与科学影响
N Engl J Med. 2009 Feb 19;360(8):816-23. doi: 10.1056/NEJMsb0803929.
9
Practicing research ethics: private-sector physicians & pharmaceutical clinical trials.践行研究伦理:私营部门医生与药物临床试验
Soc Sci Med. 2008 Jun;66(12):2495-505. doi: 10.1016/j.socscimed.2008.02.001. Epub 2008 Mar 18.
10
Medical professionalism in a commercialized health care market.商业化医疗保健市场中的医学职业精神。
JAMA. 2007 Dec 12;298(22):2668-70. doi: 10.1001/jama.298.22.2668.